DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Asparaginase
Asparaginase
Treatment of Localized Extranodal NK/T Cell Lymphoma, Nasal Type: a Systematic Review Seok Jin Kim†, Sang Eun Yoon† and Won Seog Kim*
Ciera L. Patzke, Alison P. Duffy, Vu H. Duong, Firas El Chaer 4, James A
Asparaginase As Consolidation Therapy in Patients Undergoing Bone Marrow Transplantation for Acute Lymphoblastic Leukemia
Prescribing Information | VELCADE® (Bortezomib)
Acute Lymphoblastic Leukemia (ALL) (Part 1 Of
L-Asparaginase-Induced Hepatotoxicity Treated Successfully with L-Carnitine and Vitamin B Infusion
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Erwinaze® (Asparaginase Erwinia Chrysanthemi) (Intramuscular/Intravenous)
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Overview of the Current Treatment Strategy in Extranodal NK/T-Cell Lymphoma: from Diagnosis to Recurrence
Protocol, L-Asparaginase, Cisplatin, Dexamethasone
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
Activity of Bortezomib in Glioblastoma
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
Asparaginase
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Product Monograph
Dose Intensification of Methotrexate and Cytarabine During
Top View
Chemotherapy Extravasation Management
Cytarabine Injection for Intravenous, Intrathecal and Subcutaneous Use Only
The Effect of Asparaginase Therapy on Methotrexate Toxicity and Efficacy in Children with Acute Lymphoblastic Leukemia
Combination Chemotherapy in Vitro Exploiting Glutamine Metabolism of Human Glioma and Medulloblastoma1
How to Order Chemotherapy at Shands at the University of Florida - Inpatient
Recent Strategies and Applications for L-Asparaginase Confinement
Asparaginase (Elspar)
Direct Long-Term Effects of L-Asparaginase on Rat and Human Pancreatic Islets
Pharmacokinetic Modeling of an Induction Regimen for in Vivo Combined Testing of Novel Drugs Against Pediatric Acute Lymphoblastic Leukemia Xenografts
Suppression of Murine Leukemias by I
Longitudinal Trends in Use and Costs of Targeted Therapies for Common Cancers in Taiwan: a Retrospective Observational Study
Chemotherapy Side Effects.Pdf
Individualized Dosing Guidelines for Pegasparaginase
Phase I Dose Escalating Study of Oral Cyclophosphamide in Tumour
Combination Effect of Antitumor Agents, Including Doxorubicin
Photodynamic Therapy Combined with Bcl-2/Bcl-Xl Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9x and Synergistically Enhances Apoptosis in Glioblastoma
PRODUCTION and OPTIMIZATION of L-ASPARAGINASE from Pseudomonas Aeruginosa by STRAIN IMPROVEMENT
Pharmacist Involvement in the Management of Adverse Effects
Clinical and Demographic Factors Associated with Peg-Asparaginase-Related Toxicities in Patients with Acute Lymphoblastic Leukemia
Combination Therapy with Methotrexate, Vincristine
Long-Term Follow-Up of Short Intensive Multiagent Chemotherapy
Clinical Utility and Implications of Asparaginase Antibodies in Acute Lymphoblastic Leukemia
A New Asparaginase for Acute Lymphoblastic Leukemia
L-Asparaginase, Doxorubicin, Vincristine, and Prednisolone (LHOP) Chemotherapy As a First-Line Treatment for Dogs with Multicentric Lymphoma
Schedule-Dependent Synergy and Antagonism Between Cytosine Arabinoside and L-Asparaginase on the L5178Y Murine Leukemia Simeon Alexander Schwartz Yale University
Arsenic Trioxide (As 2 O 3) Gradually Downregulates Tissue Factor
Canine Lymphoma
Bortezomib Interactions with Chemotherapy Agents in Acute Leukemia in Vitro
Essential Medicines for Cancer
Guidelines for the Use of Anti-Emetics with Chemotherapy
LYASPMEDEX Protocol
The Effect of Cancer Chemotherapeutic Agents on Fibrin Formation and Stabilization in Vitro
Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
Rescue Protocols for Canine Lymphoma
Acute Lymphoblastic Leukaemia September 2018
2020 Table of Drugs
New Aspects of Amino Acid Metabolism in Cancer
Adverse Mucocutaneous Reactions Related to Chemothera- Peutic Agents – Part II Reações Tegumentares Adversas Relacionadas Aos Agentes Antineoplásicos – Parte II
Asparaginase Dosing, Monitoring, and Toxicity Management – Adult/Pediatric – Inpatient/Ambulatory Clinical Practice Guideline
ERWINAZE (Asparaginase Erwinia Chrysanthemi)
(NCCN Guidelines®) Acute Lymphoblastic Leukemia
Drug Properties You Need to Know 1
Velcade Pediatric Postmarketing Pharmacovigilance Review
Supplementary Online Content
Hazardous Drug List
Treating Childhood Leukemia If Your Child Has Been Diagnosed with Leukemia, Your Child's Treatment Team Will Discuss the Options with You
Differential Ex Vivo Activity of Bortezomib in Newly Diagnosed Paediatric Acute Lymphoblastic and Myeloblastic Leukaemia
Medications That Are Considered Hazardous
Unexpected Mortality from the Use of E. Coli L-Asparaginase During
Influence of Intensive Asparaginase in the Treatment of Childhood Non-T-Cell Acute Lymphoblastic Leukemia1
Prevention of Methotrexate Cytotoxicity by Asparaginase Inhibition of Methotrexate Polyglutamate Formation1
Intensive High-Dose Asparaginase Consolidation Improves Survival For
Antineoplastic Drugs